The evaluation of a rapid microfluidic immunofluorescence antigen test in detecting the infectiousness of COVID-19 patients
暂无分享,去创建一个
K. Yanagihara | K. Kosai | H. Hasegawa | K. Izumikawa | T. Takazono | K. Ota | K. Sakamoto | Y. Kawamoto | M. M. N. Tun | Hina Kodama | F. Mitsumoto-Kaseida | D. Sasaki | Hiroshi Mukae | Kouichi Morita
[1] G. Rubin,et al. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial , 2022, The Lancet Respiratory Medicine.
[2] L. Hooft,et al. Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection , 2022, The Cochrane database of systematic reviews.
[3] Ö. Ergönül,et al. Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms , 2022, Clinical Microbiology and Infection.
[4] M. Siedner,et al. Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection , 2022, The New England journal of medicine.
[5] A. Cohen,et al. A nationwide analytical and clinical evaluation of 44 rapid antigen tests for SARS-CoV-2 compared to RT-qPCR , 2022, Journal of Clinical Virology.
[6] Kaitlin F. Mitchell,et al. Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection. , 2022, JAMA internal medicine.
[7] T. Kanno,et al. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees , 2022, Emerging infectious diseases.
[8] J. Tate,et al. Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures , 2022, Emerging infectious diseases.
[9] R. Arnaout,et al. Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort , 2021, Clinical Microbiology and Infection.
[10] M. Rugeles,et al. The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19 , 2021, medRxiv.
[11] J. Vandesompele,et al. The dangers of using Cq to quantify nucleic acid in biological samples; a lesson from COVID-19. , 2021, Clinical chemistry.
[12] T. Nabeshima,et al. Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling , 2021, Journal of Infection and Chemotherapy.
[13] A. Pandey,et al. Analytical sensitivity and specificity of four point of care rapid antigen diagnostic tests for SARS-CoV-2 using real-time quantitative PCR, quantitative droplet digital PCR, and a mass spectrometric antigen assay as comparator methods. , 2021, Clinical chemistry.
[14] L. Gieselmann,et al. Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals , 2021, Journal of clinical microbiology.
[15] T. Trenti,et al. Estimate false‐negative RT‐PCR rates for SARS‐CoV‐2. A systematic review and meta‐analysis , 2021, European journal of clinical investigation.
[16] D. McManus,et al. Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection , 2021, medRxiv.
[17] R. Bartenschlager,et al. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2 , 2021, Infection.
[18] Charles K. Cooper,et al. Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] E. Fischer,et al. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer , 2020, Cell.
[20] A. van Belkum,et al. Considerations for diagnostic COVID-19 tests , 2020, Nature reviews. Microbiology.
[21] Daniel B Larremore,et al. Rethinking Covid-19 Test Sensitivity - A Strategy for Containment. , 2020, The New England journal of medicine.
[22] A. Charlett,et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[23] P. V. Van Caeseele,et al. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples , 2020, Clinical Infectious Diseases.
[24] Zachary Schiffman,et al. Predicting infectious SARS-CoV-2 from diagnostic samples , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] M. Mina,et al. To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] L. Kucirka,et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.
[27] Sheng Zhang,et al. Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] Center for Disease Control and Prevention Classification System for HIV-Infected Adults and Adolescents Clinical Classification , 2020, Definitions.